US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Inventiva (0RNK) 銘柄情報

Inventiva (0RNK)

7.62

0.00

(0.00%)

終了 7月13日 12:30AM

Inventiva (0RNK) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

7.62

( - )

買値

7.62

売値

7.62

出来高

8,322

平均取引量 (3 か月)

346,837 €

財務取引量

-

0.00 日の範囲 0.00

7.62 52 週間の範囲 7.62

時価総額

企業価値

1.019B

前日終値

7.62

始値

-

時刻

最終取引時間

VWAP

-

歳入

6.76M

純利益

-354.14M

発行済株式数

236,280,202

浮動株比率 (%)

77.37%

機関投資家保有比率 (%)

71.46%

配当利回り

PER

-1.98

株価売上高倍率 (PSR)

131.4

1 株当たり利益 (EPS)

-1.9

ベータ

0.89

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome prolifer... Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France. 詳細を表示

セクター

Health Care

業界

-

ウェブサイト

inventivapharma.com

本社

Daix, France

設立

2026

Inventiva is listed in the Health Care sector of the ロンドン証券取引所 with ticker 0RNK. The last closing price for Inventiva was 7.62 €. Over the last year, Inventiva shares have traded in a share price range of 7.62 € to 7.62 €.

Inventiva currently has 236,280,202 shares in issue. The market capitalisation of Inventiva is 1.80 € billion. Inventiva has a price to earnings ratio (PE ratio) of -1.98.

Inventiva annonce la finalisation de la restructuration des BSA BEI à la suite de l'émission des Nouveaux BSA BEI

Inventiva annonce la finalisation de la restructuration des BSA BEI à la suite de l'émission des Nouveaux BSA BEI Daix (France), New York...

Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants

Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants Daix (France), New York City (New York...

Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026

Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026 Daix (France), New York City (New York, United States), July...

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 30 juin 2026

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 30 juin 2026 Daix (France), New York City (New York, United States...

Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing

Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt...

Inventiva annonce le Remboursement des Prêts BEI, le Rachat d'une partie des BSA BEI et l'émission des deux premières tranches dans le cadre du Nouveau Financement

Inventiva annonce le Remboursement des Prêts BEI, le Rachat d'une partie des BSA BEI et l'émission des deux premières tranches dans le...

Assemblée Générale Mixte du 30 juin 2026 - Modalités de mise à disposition des documents préparatoires

Assemblée Générale Mixte du 30 juin 2026 - Modalités de mise à disposition des documents préparatoires Daix (France), New York City (New York...

Statement of Total Voting Rights and Shares Forming The Company’s Share Capital as of May 22, 2026

Statement of Total Voting Rights and Shares Forming The Company’s Share Capital as of May 22, 2026 Article R. 22-10-23 of the French Commercial...

Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents

Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents Daix (France), New York City (New York, United States), June...

Information relative au nombre total de droits de vote et d’actions composant le capital social au 22 mai 2026

Information relative au nombre total de droits de vote et d’actions composant le capital social au 22 mai 2026 Article R. 22-10-23 du Code de...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	7.62	7.62	7.62	22273	7.62	DE
52	0	0	7.62	7.62	7.62	23926	7.62	DE
156	0	0	7.62	7.62	7.62	7884	7.62	DE
260	0	0	7.62	7.62	7.62	5525	7.62	DE

0RNK - Frequently Asked Questions (FAQ)

What is the current Inventiva share price?

The current share price of Inventiva is 7.62 €

How many Inventiva shares are in issue?

Inventiva has 236,280,202 shares in issue

What is the market cap of Inventiva?

The market capitalisation of Inventiva is EUR 1.8B

What is the 1 year trading range for Inventiva share price?

Inventiva has traded in the range of 7.62 € to 7.62 € during the past year

What is the PE ratio of Inventiva?

The price to earnings ratio of Inventiva is -1.98

What is the cash to sales ratio of Inventiva?

The cash to sales ratio of Inventiva is 131.4

What is the registered address of Inventiva?

The registered address for Inventiva is 50 rue de Dijon, Daix, Burgundy, 21121

What is the Inventiva website address?

The website address for Inventiva is inventivapharma.com

cojoboy

cojoboy 3分前

I've faith in this for 4years..but sad to say we are all stupid and outta our minds...nothing will come from this except Logan paying himself $250k a year on our dime..imho

nwtf

Just a matter of time and he will lose interest here Like he did over on the ERHE board and find another board to try and push his scam.

FormalMHRAconsultant

FormalMHRAconsultant 4分前

MHRA (not CHM) now have the full BNOS data analysis

well, obviously it was submitted to the MHRA. Where else would it go? You don't submit bnos to the CHM that would be absurd. I never claimed the BNOS analysis was submitted to the CHM, so this isn't the gotcha you think it is.

Nemesis18

Nemesis18 4分前

looking 4 a win

looking 4 a win 4分前

I’ve just looked at it like shaking the tree before the boom.

looking 4 a win

looking 4 a win 6分前

Hey I’m first! 😁

nwtf

What short sellers are you referencing?

Peeteman

Peeteman 10分前

IMHO this stock is drastically undervalued. St ok price could adjust at anytime. Loading at this price level makes sense. We shall see it’s s a question of when not if.

LOB

New Target for July - August .0335 -.0435 EOM

Kool Aid Man

Kool Aid Man 11分前

BDGR downgraded--'YIELD' warning flashing again.

https://www.otcmarkets.com/logos/tier/yield.png

trunkmonk

trunkmonk 13分前

Both sides
https://investorshub.advfn.com/uimage/uploads/2026/7/12/ixpmkBTCUSD_2026-07-12_16-36-57.png

Welcome2Pinkyland

Welcome2Pinkyland 18分前

I see that over 200 shares I think 266 shares traded on Friday. $EBYH for the win💯💰💵

Welcome2Pinkyland

Welcome2Pinkyland 19分前

Is this public info, inside info, or just more of your entertaining bs guess posting?

Doc logic

Doc logic 23分前

AngeloFoca,

Going alone with L in GBM is what I recall and not selling before a certain inflection point is reached where true intrinsic value is being factored into a buyout price. Rapid expansion would likely require a partner or similar. Best wishes.

xodcode

xodcode 24分前

You are beginning to sound like all ambulance chasers!

krab

He did the same in his 1st term, and repeating again in the 2nd term. Blame it on others and possibly again his wings before 2028.
These bummers never heard of multi-tasking & delegations to achieve broader successful goals !!

bobby1151

bobby1151 30分前

Ken is gone from Electrome & no reasons have been given - at least I have not seen any reason!!

Brodey79

Brodey79 34分前

Exactly had to happen sooner or later. Make way for family offices and institutions to start putting some money down in here. Relying on retail traders with few hundred bucks here and there with little true understanding of market caps/revenues/multiples/share structure will never do anything for th

skitahoe

skitahoe 34分前

Angelo,
I believe the last quarter should give us all a hint at what LP is thinking. She said the company identified existing facilities in the UK and US that could handle production of DCVax-L. She didn't say it, but clearly, they'd be equipped with many EDEN Units and serve as hubs. The

puffadder

puffadder 37分前

Did he figure out they couldn't pay him - what happened?

NotTheRealBeeny

NotTheRealBeeny 38分前

Prediction over .014 this week? Huge accumulation in the bottom zone? Same recycled shill script.

This is the exact AABB pattern every time: Bollinger squeeze hype, huge accumulation claims, price target spam, followed by more dilution and zero follow through. The chart shows the same

HoldHigh

HoldHigh 39分前

We're in the last few days of the DEA rescheduling hearing (ends 15Jul). Hopefully we can move past this fairly quickly. You know there are people everywhere that want to sue for whatever reason, so who knows what is going to transpire. I am thinking the DEA will submit a report rescheduling, howeve

LTR

BIG "if" here: attilathehunt Free 07/11/26 11:38 AM
Post #833,572
Re: #833,512: @Goats'nCrows - Yes, but one of the things that makes
IF BP was behind Citadel’s shorting, one could imagine how desperate that BP would be for Citadel to settle before discovery…

bobby1151

bobby1151 43分前

That's what happens to you when U do not SHAVE???????

stock king 1

stock king 1 45分前

Your right the only thing Steffan sells is bags of chit and lies just like he did with Gtvh and hemp inc scammed many good people …. We can all just hope karma gets him one day sooner than later …. I would be happy to see him and his family in jail imho

Exchange Traded

OMX Stockholm Consumer P...

French Republic until 03...

1.125% 15may2028

ENEFI Asset Management

La Financiere ATALIAN

VanEck Genomics and Heal...

Cleghorn Minerals

Schwab Strategic

Domestic bond 1.125% 19n...

Byrna Technologies

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。